Outbreak of KPC-2 Carbapenem-Resistant Klebsiella pneumoniae ST76 and Carbapenem-Resistant K2 Hypervirulent Klebsiella pneumoniae ST375 Strains in Northeast China: Molecular and Virulent Characteristics

Abstract

Background

Klebsiella pneumoniae has become a common pathogen that is often treated in clinical practices. It normally causes pneumonia, bacteremia, urinary tract infections, and surgical-site infections in hospitalized patients [1]. With the increasing overuse of common antibiotics, carbapenem-resistant Klebsiella pneumoniae (CRKP) strains have spread worldwide in the past two decades. CRKP infections increase the length of hospitalization, and their treatment results in higher overall costs. Its mortality rate is as high as 40–50%, which has attracted significant public attention [2].

The hypervirulent K. pneumoniae (hvKP) strain was first discovered in Taiwan in 1982 [3], and its presence was later reported by the United States, Australia, Mexico, and South Korea [4, 5]. The hvKP strain gets its name from its ability to cause community-acquired liver abscesses in young, healthy individuals. In addition, it may cause extrahepatic complications, including necrotizing fasciitis, endophthalmitis and meningitis [6]. Presently, there are at least 78 serotypes of K. pneumoniae worldwide, and serotypes K1 and K2 can cause liver abscesses [7]. These serotypes are largely characterized by their ability to produce capsular polysaccharides, which is typified by a super-viscous phenotype that enables them to avoid phagocytosis by neutrophils [8]. Several virulence factors, including the genes that regulate the mucoid phenotype A (rmpA) and siderophore production (aerobactin), have been shown to be major virulence genes of hvKP.

Unlike the multi-drug resistant form of K. pneumoniae, the hvKP strain is mostly sensitive to antibiotics other than ampicillin. With the horizontal transmission of K. pneumoniae carbapenemases (KPC), however, New Delhi metallo-beta-lactamase (NDM) and other carbapenemases appeared as carbapenem-resistant hypervirulent K. pneumoniae that are highly aggressive and capable of escape from the host’s immunological response [9]. This strain has already caused public panic due to its incurability, and its presence has been reported by major cities such as Taiwan, Beijing, Nanchang and Zhejiang [3, 4, 7, 10]. In addition, its high mortality and prevalence rates call for further studies. We previously reported the mechanism responsible for the resistance of CRKP to antibiotics [11]. In this study, we address the virulence of CRKP isolates, which will enable us to compare the molecular characteristics and the virulence of the ST76 CRKP strain with the KPC-2 resistance gene in this region and to provide epidemiological data for patients infected with CRKP. To the best of our knowledge, this is the first report to describe the genomic background and the virulence of the carbapenem-resistant K2 hypervirulent K. pneumoniae ST375 strain in Heilongjiang Province, Northeast China.

Methods

Collection and identification of K. pneumoniae isolates

Forty-four CRKP isolates were collected from patients at the 1980-bed First Affiliated Hospital of Jiamusi University in Heilongjiang Province, northeast China, from January 2015 to December 2017. The isolates were identified as CRKP strains by the VITEK-2 System (bioMe'rieux). The minimal inhibitory concentrations (MICs) of imipenem and meropenem were verified by the E-test, and the results were interpreted according to the 2016 Clinical and Laboratory Standard Institute Guidelines. Hypermucoviscosity was determined using the string test. Quality control strains (Escherichia coli ATCC 25922, Salmonella H9812 and K. pneumoniae ATCC 700603) were used for pulsed-field gel electrophoresis, as well as antimicrobial susceptibility and serum complement-mediated killing assays. Nine out of forty-four CRKP strains died after completing the molecular biology experiments due to improper preservation.

Multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE)

MLST was used to screen the 44 CRKP strains by amplifying seven housekeeping genes (gapA, infB, mdh, pgi, phoE, rpoB and tonB) expressed by K. pneumoniae according to the protocol at (http://bigsdb.pasteur.fr/klebsiella/primers_used.html). eBURST Software (ver 3) was used to analyze the sequence types (STs). Clonal complexes (CCs) were defined as those originating from the same genotype; they shared alleles with another member of the group at six out of seven loci and predicted the ST with the largest number of a single locus variant (SLV). PFGE was performed on 35 CRKP strains that were digested with XbaI for 3 h at 37°C. The digested fragments were separated on a 1% Seakem Gold agarose gel for 18 h at 14°C using the Bio-Rad CHEF MAPPER System. The band patterns were analyzed using BioNumerics 7.0 Software. Clusters were defined as DNA patterns sharing ≥85% similarity. PFGE patterns were identified as previously described [12].

String test

CRKP strains were incubated overnight on blood agar. A single colony was touched with a loop and stretched outward. The length of the viscous string was pulled upward and measured. A positive string test result was defined as a string longer than 5 mm. The string test was repeated three times for each strain, and determined the final result.

Detection of capsular serotyping and virulence-associated genes

Forty-four CRKP strains belonging to K1, K2, K5, K20, K54 and K57 serotypes were identified by PCR [13]. Virulence-associated genes (rmpA, uge, magA, kfu, mrkD, fimH, kpn, iroNB, alls, wcaG and aerobactin) were amplified by PCR as previously described [14-16]. The amplified transcripts were sequenced, and BLAST was used to determine their identities.

Biofilm formation assay

In brief, 10 μl of the 0.5 McFarland bacterial standard and 200 μl of Luria-Bertani (LB) broth were inoculated into the wells of a 96-well microplate, with four wells per strain, and the microplate was incubated at 37°C for 24 h. Thereafter, the LB broth was removed, and the bacterial cells were stained with 200 μl of 0.1% crystal violet at room temperature for 15 min, then removed the due. The wells were washed free of dye with PBS and then dried. The absorbance was measured with a microplate reader set at 570 nm after adding 200 μl of ethanol for 10 min into the wells. The yield of biofilm formation of the strains was interpreted as follows: OD >0.6 as strong-producing, 0.4< OD ≤0.6 as moderate-producing and OD <0.4 as weak-producing.

Serum complement-mediated killing assay

Venous blood was collected from 10 healthy volunteers, who had provided written informed consent before participation in the studies. Sera were obtained and stored at -80°C until use. A bacterial stock at mid-log-phase was diluted to 1 × 10⁶ colony-forming units (CFUs)/ml in 0.9% saline, combined with serum at a 1:3 volume ratio, and then incubated at 37°C. Serial dilutions were plated on MHA and incubated for 0, 1, 2, and 3 h to determine the number of colonies. Each sample was tested three times. The results were presented as means, and the final results were expressed as previously described [17]. K. pneumoniae ATCC 700603 and K. pneumoniae Jms100, which exhibits a hypermucoviscous phenotype and is sensitive to all antibiotics except ampicillin, was isolated from a liver abscess from a patient in our hospital and used for comparison.

Whole genome sequencing

JmsCRE57 genomic DNA was extracted from overnight cultures using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany). The Illumina HiSeq 2000 System (Illumina Inc., San Diego, CA, USA), which generates 300–500bp paired-end sequences, and the PacBio System (Pacific Biosciences, Menlo Park, CA, USA), which assembles a 10-kb fragment library, were used via SOAPdenovo (ver 2.04). The genomic sequences were annotated using the Prokka 1.12 Program. The expression of rRNAs and tRNAs was predicted using Barrnap 0.4.2 Software and tRNAscan-SE Software (ver 1.3.1), respectively, whereas bacterial gene expression was predicted using Glimmer 3.02 Software. The annotated information for the predicted genes was obtained using BLAST aligned with NRGene, EggNOG and GO Databases. The PlasmidFinder Database and BLASTn were used to identify the incompatibility groups. The antimicrobial resistance genes and virulence genes were identified after uploading the assembled genome at ResFinder (https://bitbucket.org/genomicepidemiology/resfinder) and the Virulence Factor Database (VFDB) (http://www.mgc.ac.cn/VFs/). The JmsCRE57 genomic sequence was deposited into GenBank under accession number SAMN10995714.

Statistical analysis

Statistical analysis was performed using IBM SPSS Statistics Software (ver 20.0) and Graphpad Prism Software (ver 7). Data were presented as medians or means ± standard deviation.

Results

Clinical characteristics of CRKP isolates

The clinical characteristics and antibiotic susceptibility of 44 CRKP isolates obtained from different clinical specimens, including 38 respiratory secretions (86.3%), five blood specimens (13.6%) and one wound (2.3%), were investigated. The mean ± standard deviation age of the patients was 60.3 ± 15.2 (range, 16–86) years. Most CRKP isolates were obtained from patients at the neurology unit and ICU, with a separation rate of 40.9% and 38.6%, respectively, followed by 9.1%, 6.8%, 2.35% and 2.35% at the units of emergency, hematology, orthopedics and cardiac surgery, respectively. The mortality rate was 27.3%. Most patients presented with severe underlying diseases and received several antibiotics during hospitalization. The clinical characteristics are listed in Table 1.

Molecular characteristics of CRKP isolates

Eight STs were identified among 44 CRKP isolates, which included 37 isolates for ST76 and one isolate each for ST11, ST323, ST896, ST2964, ST375, ST530 and ST3335. ST76 (81.8%), the most prevalent ST, belonged to CC76. One carbapenem-resistant hypervirulent K. pneumoniae isolate belonged to ST375 (CC65), whereas another isolate, ST3335, was a novel ST. ST323 and ST896 belonged to CC23 and CC896, respectively. There was no clonal complex correlation between STs (Figure 1). PFGE showed one cluster; it was calculated by the unweighted pair group method with arithmetic mean (UPGMA) using a dice coefficient (Figure 2). Cluster A had 31 isolates of ST76 (88.57%), which represented the largest group of STs. Within this group, each isolate had a similar PFGE pattern that exceeded SAB 0.9, thus indicating that most of the isolates shared a clonal relationship. ST3335 was similar to cluster A with SAB 0.8. ST530, ST11 and ST375 showed different PFGE patterns with SAB 0.71, suggesting that they had a polyclonal origin.

Genetic characterization of CRKP isolates

We previously reported the PCR amplification of resistance genes [11]. Each isolate in this study expressed resistance genes (Table 1). The prevalent bla_KPC-2 gene was detected in 41 isolates (93.2%), whereas bla_IMP-4 and bla_NDM genes were detected in only two isolates (4.5% each). The prevalent β-lactamase genes bla_SHV, bla_CTX-M and bla_TEM were mostly expressed by CRKP isolates at ratios of 95.5% (42/44), 90.9% (40/44) and 90.9% (40/44), respectively. Two isolates expressed bla_DHA (4.5% each). Each CRKP isolate in this study expressed at least two resistance genes, whereas 68.2% CRKP strains co-expressed bla_KPC-2, bla_CTX-M-15, bla_SHV and bla_TEM genes.

String test, capsular serotyping and virulence-associated genes among CRKP isolates

Only one (JmsCRE57) out of 44 CRKP isolates (2.3%) exhibited the hypermucoviscous phenotype during the string test and capsular serotyping. The remaining 43 CRKP isolates were not successfully serotyped. The virulence-associated genes detected by PCR for each isolate are listed in Table 1. The carbapenem-resistant hypervirulent K. pneumoniae K2 serotype expressed several virulence-associated genes, including uge, mrkD, fimH, kpn, aerobactin and rmpA. Each CRKP isolate in this study expressed the uge gene. Most CRKP isolates expressed fimH (97.7%), mrkD (97.7%) and kpn (97.7%). Only JmsCRE62 expressed the alls gene, and the detection rate was 2.4% for aerobactin, rmpA and alls genes. None of the isolates expressed magA, kfu, iroNB and wcaG genes.

Biofilm formation

Biofilm formation was observed in 35 CRKP isolates (Figure 3). The highest biofilm producer was ST3335 isolate JmsCRE62 (0.95), which did not exhibit the capsule serotype and the hypermucoviscous phenotype. The second highest biofilm producer was ST76 isolate JmsCRE54 (0.73), whereas ST375 isolate JmsCRE57 (0.69) was the third highest. Approximately 14.3% (5/35) of the isolates were classified as strong-producers, 17.1% (6/35) as moderate-producers and 68.6% (24/35) as weak-producers. Compared with the other STs (median A570 of 0.44), ST76 was the low biofilm producer (median A570 of 0.35).

Serum complement-mediated killing resistance

The results of the serum complement-mediated killing assay are shown in Figure 4. Jms100, which was isolated from a liver abscess and exhibited a hypermucoviscous phenotype, was sensitive to all antibiotics, except ampicillin. ST375 isolate JmsCRE57, ST3335 isolate JmsCRE62, ST11 isolate JmsCRE47, ST76 isolate JmsCRE23 and ATCC 700603 were all sensitive to serum complement-mediated killing (grade 2, 0%, 20.72%, 6.68%, 25.03% and 2.4%, respectively). JmsCRE57, which was highly sensitive to serum complement-mediated killing, died within 3h. ST530 isolate JmsCRE59 was moderately sensitive to serum complement-mediated killing (grade 3, 0.29%). The growth rate of Jms100 was the highest; however, which expressed serum resistance (grade 6, 112.2%) and successfully avoided the complement-mediated serum killing in vivo.

Genome sequencing and analysis

The sequencing of JmsCRE57 revealed a total of 7,457,750 (1,098,918,433 bp) paired-end reads that were generated with the Illumina HiSeq 2000 System and 62,801 (417,488,124 bp) raw reads that were produced with the PacBio System. Our analysis showed that the JmsCRE57 genome consisted of a circular chromosome of 4,649,643 bp and three antibiotic resistance plasmids of tig00000041 (121,129 bp), tig00000017 (83,848 bp) and tig00000012 (688,226 bp), and a virulent tig00000014 plasmid (199,142 bp). The chromosome features of JmsCRE57 are summarized in Figure 5. Aminoglycoside resistance genes aph(3'')-Ib and aph(6)-Id, the quinolone resistance gene qnrB1, fluoroquinolone and aminoglycoside resistance genes aac(3)-IIa and aac(6')-Ib-cr, β-lactamase resistance genes bla_OXA-1 and bla_TEM-1B, the phenicol resistance gene catB4, the sulphonamide resistance gene sul2 and the trimethoprim resistance gene dfrA14 were also expressed by the tig00000017 plasmid. The tig00000017 plasmid resistance genes are shown in Figure 6. The plasmid carrying the carbapenem resistance gene bla_KPC-2 and the extended-spectrum b-lactamase gene bla_CTX-M-15 on the tig00000041 plasmid belonged to the IncFIB (pQil) incompatibility group. The plasmid carrying the extended-spectrum b-lactamase gene bla_SHV-99 on the tig00000012 plasmid. BLASTn analysis revealed that the tig00000041 plasmid, with a 48% query coverage, was 99% similar to the pKPHS2 plasmid (GenBank accession number CP003224.1), which was isolated from a patient in Shanghai. A schematic representation of the genetic environment of the bla_KPC-2 and bla_CTX-M-15 genes on the tig00000041 plasmid is shown in Figure 7.

JmsCRE57-associated virulence genes mainly included the capsular polysaccharide gene rmpA; siderophore-associated genes iucBC, iutA, iroBD and aerobactin present on the tig00000014 plasmid; fimbrial adhesin genes fimA-H and mrkD and siderophore-associated genes iutA and entAB present on the chromosome (Figure 8).

Discussion

This retrospective study was conducted on 44 cases presenting with various diseases caused by CRKP from January 2015 to December 2017 at the First Affiliated Hospital of Jiamusi University in Heilongjiang Province, northeast China. The antibiotic susceptibility of 44 CRKP isolates was previously reported[11]. All strains were resistant to carbapenem; the resistance rate to β-lactamase inhibitor combinations, third-generation cephems and aminoglycosides was 93.18%, 100% and 93.18%, respectively. All isolates were sensitive to amikacin, and the resistance rate to levofloxacin was 18.2%. The detection rate of the bla_KPC-2 gene, a key enzyme of carbapenem resistance, was 93.2%. The detection rates of the extended-spectrum β-lactamases bla_SHV, bla_CTX-M and bla_TEM were 95.46%, 86.36% and 90.9%, respectively. Taken collectively, these results support the contention that the resistance of CRKP strains is caused by the expression of multiple resistance genes. Here, ST76 was the predominant clone (81.8%), and the PFGE pattern, which exceeded SAB 0.9, showed that all ST76 isolates shared a clonal relationship. The CRKP isolates investigated in this study mainly concentrated in the neurosurgery unit and ICU, suggesting that there might have been an outbreak of ST76 CRKP that subsequently spread to additional units.

HvKP strains are often identified by a positive string test. However, not all hvKP strains exhibit the hypermucoviscous phenotype, which may lead to the undetection of many hvKPs [14, 18]. Aerobactin, a key virulence gene, mediates iron transport in bacteria; it has also been used in the identification of hvKP [19]. Here, only one CRKP isolate exhibited a positive string test, and this isolate expressed virulence-associated genes uge, mrkD, fimH, kpn, aerobactin and rmpA. According to the aforementioned criteria, this isolate was identified as a carbapenem-resistant hypervirulent K. pneumoniae strain with a ST375 K2 serotype. Interestingly, a previous study reported that ST23, the most prevalent hvKP, strongly correlated with the K1 serotype. However, MLSTs, such as ST65, ST66, ST86, ST374, ST375 and ST380, also associated with the K2 serotype [20]. Our results showed a single locus difference between ST375 and ST65. Likewise, another earlier study reported that ST375 belonged to the K2 serotype and was sensitive to most antibiotics [21], whereas JmsCRE57 was resistant to most antibiotics, except amikacin, polymyxin and tigecycline. On the other hand, Guo et al. reported that K2 serotype isolates caused more invasive infections than K1 serotype isolates [1], which is consistent with our findings on the patient with spontaneous subarachnoid hemorrhage. Thus, an understanding of the genetic background and virulence of hvKP strains is crucial.

HvKP strains are characterized by the presence of capsular polysaccharides (K antigen), fimbriae, lipopolysaccharides (O antigen) and siderophores (aerobaction and yersiniabactin) [14]. Here, we investigated 11 virulence-associated genes in 44 CRKP isolates. We found that these isolates expressed fimH, mrkD and kpn genes at a rate of 97.7%, and almost existed in all CRKP strains. The fimH gene encodes type 1 fimbrial and the mrkD gene encodes type 3 fimbrial, which play critical roles in adhesion to the respiratory tract and urethra, as well as in bacterial infections and biofilm formation. The mrkD gene, regardless of whether it is hypervirulent or non-hypervirulent [22], is often detected in cases of ventilator-associated pneumonia caused by K. pneumoniae. Here, 83.8% of the isolates were mainly harvested from respiratory tract secretions, accounting for 72.7% of the total number of patients diagnosed with pneumonia. Furthermore, only JmsCRE62 expressed the alls gene, which mediates allantoin metabolism and facilitates the development of liver abscesses caused by K. pneumoniae. Although a previous study reported a strong correlation between the alls gene and the K1 serotype [23], JmsCRE62 was unsuccessfully serotyped in this study.

Biofilm formation inhibits the penetration of drugs, thus increasing antibiotic resistance, which further complicates the clinical treatment of K. pneumoniae infections [24]. K. pneumoniae strains can also avoid phagocytosis by neutrophils, thus causing refractory and chronic infections. A previous study reported that biofilm formation required the type 3 fimbrial and adhesion factor mrkD [25]. Here, the detection rate of mrkD was 97.7%, whereas that of strong biofilm was 14.3%, which signifies a significant difference. Biofilm formation also involves different biomolecules, including extracellular polysaccharides, proteins and DNA.

The complement system, an important component of the immune system in humans, promotes the membrane attack and phagocytosis of foreign cells such as bacteria. K. pneumoniae produce capsular polysaccharides that make this species of bacteria resistant to serum complement-mediated killing, thus promoting their survival. Although JmsCRE57 was the only strain in this study to produce capsular polysaccharides, it was killed by the complement system, which is different from many carbapenem-resistant hypervirulent K. pneumoniae strains that are resistant to serum complement-mediated killing [7, 26, 27]. JmsCRE57 was harvested from a 71-year-old female with hypertension and arrhythmia, who was hospitalized 9 h after suffering from a spontaneous subarachnoid hemorrhage. This patient was previously treated with cefoselis and ceftriaxone, and she was hospitalized in the neurosurgery unit and ICU for 48 days. In addition to being sensitive to amikacin and tigecycline, this strain is also resistant to quinolones, aminoglycosides, macrolides, cephalosporins, β-lactamase inhibitor combinations and carbapenems. During hospitalization, the patient was not treated with antibiotics, except that she received fosfomycin and etimicin to prevent urinary tract infections due to catheter use. Subsequently, her health improved, and the patient was discharged, suggesting that this strain was sensitive to serum complement-mediated killing. Multi-drug resistant bacteria are generally considered to have higher fitness or less virulence [28]. Gottig suggests that the acquisition of new plasmids and other mobile genetic elements can reduce fitness [29]. The whole genome sequencing results showed that JmsCRE57 mainly contained three antibiotic resistant plasmids and one virulence plasmid, which increased the fitness cost of the strain, rendering it easily killed by the immune system. Further studies are needed on the fitness of carbapenem-resistant hypervirulent K. pneumoniae strains.

The tig00000014 virulence plasmid in JmsCRKP57 belonged to the IncHI1B group, similar to the pLVPK (AY378100) virulence plasmid belonging to the IncHI1B/IncFIB group that was collected from K. pneumoniae CG43, which was mainly composed of mucoid phenotype genes and siderophore-associated genes. JmsCRKP57 also had fimA-H, mrkD, iutA and entAB genes on the chromosome, which might also be typical of ST375 K. pneumoniae.

The horizontal transmission of mobile genes, such as plasmids, phages, integration and conjugated elements and insertion elements, is a key factor in the prevalence of K. pneumoniae outbreaks [30]. Here, the tig00000041 plasmid expressing both bla_KPC-2 and bla_CTX-M-15 genes was identified; it was located on the TnpA transposon and found to have insertion elements at both ends. When a transposon is inserted into different plasmid backbones, new KPC-2 and CTX-M plasmid can be formed. This phenomenon might have caused the outbreak at the hospital. Presently, two mechanisms can explain the development of carbapenem-resistant hypervirulent K. pneumoniae strains. In the first mechanism, Siu et al. reported successful transfer of a KPC-producing plasmid into a hvKP strain, which no longer only resisted ampicillin and streptomycin but also all b-lactams without losing virulence [31]. In the second mechanism, Gu et al. reported successful transfer of a 170-kbp pLVPK-like virulent plasmid into ST11 CRKP, which formed ST11 CRKP with K1 hypervirulence [10]. A plasmid expressing the bla_CTX-M gene has also been shown to be compatible with various hvKP strains [32]. If large-scale horizontal transmission is possible, hvKP strains can become highly resistant to antibiotics. Here, 86.36% of CRKP isolates expressed the bla_CTX-M gene, suggesting that this high carrier rate might facilitate horizontal transmission and lead to the formation of a highly resistant hvKP strain. Regardless, both mechanisms can result in a widespread outbreak of carbapenem-resistant hypervirulent K. pneumoniae strains; therefore, effective control measures are critical.

Conclusions

To our best knowledge, we are the first group to report the genetic background and virulence characteristics of the carbapenem-resistant K2 hypervirulent K. pneumoniae ST375 isolate in northeast China. This isolate expressed multiple antibiotic resistance and virulence genes. Furthermore, our study identified an outbreak of KPC-2 CRKP ST76 in a hospital in Heilongjiang Province, northeast China, which was caused by classic K. pneumoniae strains; however, both strains expressed adherence virulence genes. The outbreak of CRKP strains and emergence of hypervirulence forces us to promote awareness and to strengthen epidemiological surveillance and infection control measures in our hospital.

Abbreviations

CRKP: carbapenem-resistant K. pneumoniae ; MLST: multilocus sequence typing; PFGE: pulsed-field gel electrophoresis; hvKP: hypervirulent K. pneumoniae ; rmpA: regulate the mucoid phenotype A; aerobactin: siderophore production ; KPC: K. pneumoniae carbapenemases; NDM: New Delhi metallo-beta-lactamase; MICs: minimal inhibitory concentrations; ATCC: American Type Culture Collection; STs: sequence types; CCs: Clonal complexes; SLV: single locus variant; CFUs: colony-forming units; LB: Luria-Bertani.

Declarations

Acknowledgments

We thank Dr. Ming-Gui Wang from Huashan Hospital, affiliated with Fudan University, and Dr. Yun-Song Yu from Sir Run Run Shaw Hospital, affiliated with Zhejiang University, for their assistance. We thank the team of curators at the Institute Pasteur MLST System (Paris, France) for importing novel alleles, profiles and/or isolates at http://bigsdb.web.pasteur.fr.

Funding

This work was supported by the Excellent Team of Young Teachers Foundation of Heilongjiang Province (2018-KYYWF-0916), Heilongjiang Provincial Health and Family Planning Commission on Scientific Research Project (2017-405) and Research Project of Yongchuan Hospital Affiliated to Chongqing Medical University (YJYJ201902).

Author Contributions

All authors contributed to this work. XLZ and JSZ conceived and designed the experiments; SSS, YXZ, YF and CJL performed the experiments; LY, YW and MJB analyzed the data and YCW wrote the paper. SSS and YXZ are the first authors. All authors reviewed and approved the final manuscript.

Ethics approval and consent to participate

The experimental protocols were approved by the Ethics Committee of Jiamusi University Clinical Medical College for Research. The committee’s reference number is 2018025. Individual informed consent was waived by the ethics committee listed above because this study used currently existing sample collected during the course of routine medical care and did not pose any additional risks to the patients.

Consent for publication

Not applicable

Competing Interests

The authors of this study declare no commercial relationships and no conflicts of interest.

References

1. Guo Y, Wang S, Zhan L, Jin Y, Duan J, Hao Z, Lv J, Qi X, Chen L, Kreiswirth BN et al: Microbiological and Clinical Characteristics of Hypermucoviscous Klebsiella pneumoniae Isolates Associated with Invasive Infections in China. Frontiers in cellular and infection microbiology 2017, 7:24.
2. Zheng B, Dai Y, Liu Y, Shi W, Dai E, Han Y, Zheng D, Yu Y, Li M: Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infections in Eastern China. Frontiers in microbiology 2017, 8:1061.
3. Siu LK, Fung CP, Chang FY, Lee N, Yeh KM, Koh TH, Ip M: Molecular typing and virulence analysis of serotype K1 Klebsiella pneumoniae strains isolated from liver abscess patients and stool samples from noninfectious subjects in Hong Kong, Singapore, and Taiwan. Journal of clinical microbiology 2011, 49(11):3761-3765.
4. Yao B, Xiao X, Wang F, Zhou L, Zhang X, Zhang J: Clinical and molecular characteristics of multi-clone carbapenem-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in a tertiary hospital in Beijing, China. International journal of infectious diseases 2015, 37:107-112.
5. Bocanegra-Ibarias P, Garza-Gonzalez E, Morfin-Otero R, Barrios H, Villarreal-Trevino L, Rodriguez-Noriega E, Garza-Ramos U, Petersen-Morfin S, Silva-Sanchez J: Molecular and microbiological report of a hospital outbreak of NDM-1-carrying Enterobacteriaceae in Mexico. PloS one 2017, 12(6):e0179651.
6. Struve C, Roe CC, Stegger M, Stahlhut SG, Hansen DS, Engelthaler DM, Andersen PS, Driebe EM, Keim P, Krogfelt KA: Mapping the Evolution of Hypervirulent Klebsiella pneumoniae. mBio 2015, 6(4):e00630.
7. Liu Y, Liu PP, Wang LH, Wei DD, Wan LG, Zhang W: Capsular Polysaccharide Types and Virulence-Related Traits of Epidemic KPC-Producing Klebsiella pneumoniae Isolates in a Chinese University Hospital. Microbial drug resistance 2017, 23(7):901-907.
8. Diago-Navarro E, Chen L, Passet V, Burack S, Ulacia-Hernando A, Kodiyanplakkal RP, Levi MH, Brisse S, Kreiswirth BN, Fries BC: Carbapenem-resistant Klebsiella pneumoniae exhibit variability in capsular polysaccharide and capsule associated virulence traits. The Journal of infectious diseases 2014, 210(5):803-813.
9. Yang Z, Liu W, Cui Q, Niu W, Li H, Zhao X, Wei X, Wang X, Huang S, Dong D et al: Prevalence and detection of Stenotrophomonas maltophilia carrying metallo-beta-lactamase blaL1 in Beijing, China. Frontiers in microbiology 2014, 5:692.
10. Gu D, Dong N, Zheng Z, Lin D, Huang M, Wang L, Chan EW-C, Shu L, Yu J, Zhang R et al: A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. The Lancet Infectious Diseases 2018, 18(1):37-46.
11. Gong X, Zhang J, Su S, Fu Y, Bao M, Wang Y, Zhang X: Molecular characterization and epidemiology of carbapenem non-susceptible Enterobacteriaceae isolated from the Eastern region of Heilongjiang Province, China. BMC infectious diseases 2018, 18(1):417.
12. Liang Y, Yin X, Zeng L, Chen S: Clonal replacement of epidemic KPC-producing Klebsiella pneumoniae in a hospital in China. BMC infectious diseases 2017, 17(1):363.
13. Fang CT, Lai SY, Yi WC, Hsueh PR, Liu KL, Chang SC: Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clinical infectious diseases 2007, 45(3):284-293.
14. Fu L, Huang M, Zhang X, Yang X, Liu Y, Zhang L, Zhang Z, Wang G, Zhou Y: Frequency of virulence factors in high biofilm formation blaKPC-2 producing Klebsiella pneumoniae strains from hospitals. Microbial pathogenesis 2018, 116:168-172.
15. El Fertas-Aissani R, Messai Y, Alouache S, Bakour R: Virulence profiles and antibiotic susceptibility patterns of Klebsiella pneumoniae strains isolated from different clinical specimens. Pathologie-biologie 2013, 61(5):209-216.
16. Jian-Li W, Yuan-Yuan S, Shou-Yu G, Fei-Fei D, Jia-Yu Y, Xue-Hua W, Yong-Feng Z, Shi-Jin J, Zhi-Jing X: Serotype and virulence genes of Klebsiella pneumoniae isolated from mink and its pathogenesis in mice and mink. Scientific reports 2017, 7(1):17291.
17. Podschun R, Sievers D, Fischer A, Ullmann U: Serotypes, hemagglutinins, siderophore synthesis, and serum resistance of Klebsiella isolates causing human urinary tract infections. The Journal of infectious diseases 1993, 168(6):1415-1421.
18. Zhang R, Lin D, Chan EW, Gu D, Chen GX, Chen S: Emergence of Carbapenem-Resistant Serotype K1 Hypervirulent Klebsiella pneumoniae Strains in China. Antimicrobial agents and chemotherapy 2016, 60(1):709-711.
19. Russo TA, Olson R, MacDonald U, Beanan J, Davidson BA: Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo. Infection and immunity 2015, 83(8):3325-3333.
20. Wang X, Xie Y, Li G, Liu J, Li X, Tian L, Sun J, Ou HY, Qu H: Whole-Genome-Sequencing characterization of bloodstream infection-causing hypervirulent Klebsiella pneumoniae of capsular serotype K2 and ST374. Virulence 2018, 9(1):510-521.
21. Liao CH, Huang YT, Chang CY, Hsu HS, Hsueh PR: Capsular serotypes and multilocus sequence types of bacteremic Klebsiella pneumoniae isolates associated with different types of infections. European journal of clinical microbiology & infectious diseases 2014, 33(3):365-369.
22. Yan Q, Zhou M, Zou M, Liu WE: Hypervirulent Klebsiella pneumoniae induced ventilator-associated pneumonia in mechanically ventilated patients in China. European journal of clinical microbiology & infectious diseases 2016, 35(3):387-396.
23. Yu WL, Ko WC, Cheng KC, Lee CC, Lai CC, Chuang YC: Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes. Diagnostic microbiology and infectious disease 2008, 62(1):1-6.
24. Vuotto C, Longo F, Balice MP, Donelli G, Varaldo PE: Antibiotic Resistance Related to Biofilm Formation in Klebsiella pneumoniae. Pathogens (Basel, Switzerland) 2014, 3(3):743-758.
25. Stahlhut SG, Chattopadhyay S, Kisiela DI, Hvidtfeldt K, Clegg S, Struve C, Sokurenko EV, Krogfelt KA: Structural and population characterization of MrkD, the adhesive subunit of type 3 fimbriae. Journal of bacteriology 2013, 195(24):5602-5613.
26. Mei YF, Liu PP, Wan LG, Liu Y, Wang LH, Wei DD, Deng Q, Cao XW: Virulence and Genomic Feature of a Virulent Klebsiella pneumoniae Sequence Type 14 Strain of Serotype K2 Harboring blaNDM-5 in China. Frontiers in microbiology 2017, 8:335.
27. Chiang TT, Yang YS, Yeh KM, Chiu SK, Wang NC, Lin TY, Huang LY, Chang FY, Siu LK, Lin JC et al: Quantification and comparison of virulence and characteristics of different variants of carbapenemase-producing Klebsiella pneumoniae clinical isolates from Taiwan and the United States. J Microbiol Immunol Infection 2016, 49(1):83-90.
28. Hennequin C, Robin F: Correlation between antimicrobial resistance and virulence in Klebsiella pneumoniae. European journal of clinical microbiology & infectious diseases 2016, 35(3):333-341.
29. Gottig S, Riedel-Christ S, Saleh A, Kempf VA, Hamprecht A: Impact of blaNDM-1 on fitness and pathogenicity of Escherichia coli and Klebsiella pneumoniae. International journal of antimicrobial agents 2016, 47(6):430-435.
30. Chen L, Mathema B, Chavda KD, DeLeo FR, Bonomo RA, Kreiswirth BN: Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends in microbiology 2014, 22(12):686-696.
31. Siu LK, Huang DB, Chiang T: Plasmid transferability of KPC into a virulent K2 serotype Klebsiella pneumoniae. BMC infectious diseases 2014, 14:176.
32. Zhang Y, Zhao C, Wang Q, Wang X, Chen H, Li H, Zhang F, Li S, Wang R, Wang H: High Prevalence of Hypervirulent Klebsiella pneumoniae Infection in China: Geographic Distribution, Clinical Characteristics, and Antimicrobial Resistance. Antimicrobial agents and chemotherapy 2016, 60(10):6115-6120.

Tables

Table 1. Clinical characteristics, drug resistance genes and virulence-associated genes of 44 CRKP isolates.

Note: ICU, Intensive Care Unit; ETP, ertapenem; IMP, imipenem; SCF, cefoperazone/sulbactam; LVX, levofloxacin; TZP, piperacillin/tazobactam; CRO, ceftriaxone; LZD, linezolid; CTT, cefotetan; MFX, moxifloxacin; VAN, vancomycin; CLI, clindamycin; CMZ, cefmetazole; AMK, amikacin; MSU, mezlocillin/sulbactam; CFZ, cefazolin; FOX, cefoxitin; MEM, meropenem; FOF, fosfomycin; FEP, cefepime; ATM, aztreonam; VRC, voriconazole; -,unmedicated; NR, no record; MLST, multilocus sequence typing. Resistance and virulence genes were amplified by PCR.